La
Laekna
Shanghai CNFounded 201850 employees
Private CapbiotechPrivateOncology
Platform: PI3K/mTOR
Market Cap
N/A
All Drugs
3
Clinical Trials
5
Failed / Terminated
2
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| LAE-3866 | LAE-3866 | Phase 1/2 | 1 | FXIa | FLEwing Sarcoma | ||
| Bemaosocimab | LAE-9406 | Phase 3 | 2 | IL-17A | RettNarcolepsy | ||
| LAE-436 | LAE-436 | Preclinical | 2 | MET | WMMelanoma |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (5)